Division of Cardiology, Department of Pediatrics, Stanford University, Palo Alto, CA, USA.
Division of Nephrology, Department of Pediatrics, Stanford University, Palo Alto, CA, USA.
Best Pract Res Clin Anaesthesiol. 2017 Sep;31(3):427-439. doi: 10.1016/j.bpa.2017.08.007. Epub 2017 Aug 24.
Acute kidney injury (AKI) is highly prevalent among hospitalized children, especially those who are critically ill. The incorporation of pediatric elements into consensus definitions has led to a greater understanding of pediatric AKI epidemiology, risk factors, and outcomes. The best available data suggest that AKI occurs in 5% and 27% of non-critically ill and critically ill children, respectively. Additionally, AKI and fluid overload are independently associated with worse outcomes including mortality. Currently, the diagnosis of AKI relies upon urine output and creatinine measurements, both of which pose unique problems in children. However, novel biomarker discovery and new risk stratification techniques have led to enhanced detection and diagnostic strategies. Although no specific treatments exist, strategies designed to prevent AKI are being developed and there is growing evidence that early detection may improve outcomes. We hope that advances in AKI management will follow the diagnostic innovations seen in the past decade.
急性肾损伤(AKI)在住院儿童中非常普遍,尤其是那些危重症患儿。将儿科元素纳入共识定义,使人们对儿科 AKI 的流行病学、危险因素和结局有了更深入的了解。现有最佳数据表明,非危重症和危重症患儿中分别有 5%和 27%发生 AKI。此外,AKI 和液体超负荷与死亡率等更差的结局独立相关。目前,AKI 的诊断依赖于尿量和肌酐测量,这两者在儿童中都存在独特的问题。但是,新型生物标志物的发现和新的风险分层技术已经导致检测和诊断策略的改进。虽然没有特定的治疗方法,但正在制定预防 AKI 的策略,越来越多的证据表明早期检测可能改善结局。我们希望 AKI 管理方面的进展将遵循过去十年中在诊断方面的创新。